3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
9
Recruiting
6
Unknown
4
Terminated
4
Not yet recruiting
2
Active not recruiting
2
Sponsor Class
OTHER
103
NIH
4
INDUSTRY
3
NETWORK
2
OTHER_GOV
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Prostate Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
18
Cyclophosphamide
17
Magnetic Resonance Spectroscopy
16
Dexamethasone
15
Cisplatin
14
Vincristine
13
Radiotherapy
13
Radiation
11
Etoposide
10
Carboplatin
10
durvalumab
9
Radiotherapy, Intensity-Modulated
9
Paclitaxel
9
Doxorubicin
8
Cytarabine
8
Temozolomide
7
Rituximab
7
Prednisone
7
Lenalidomide
7
Irinotecan
7
Gemcitabine
7
Fluorouracil
7
Docetaxel
7
Bortezomib
7
Biopsy
7
daratumumab
6
Platinum
6
Leucovorin
6
Capecitabine
6
tremelimumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
NETWORK
×
Radiosurgery
×
Clear all
NCT03784755
2026-03-27
PLATON
Canadian Cancer Trials Group
Phase NA
Active not recruiting
409 enrolled
NCT03965468
2026-02-09
CHESS
ETOP IBCSG Partners Foundation
Phase 2
Active not recruiting
96 enrolled